Free Trial

Cartesian Therapeutics (RNAC) SEC Filings & 10K Form

Cartesian Therapeutics logo
$9.84 -0.21 (-2.09%)
Closing price 09/2/2025 04:00 PM Eastern
Extended Trading
$10.01 +0.17 (+1.73%)
As of 09:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cartesian Therapeutics SEC Filings

DateFilerForm TypeView
08/07/2025
6:05 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
6:08 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/16/2025
6:06 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
6:02 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:04 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:05 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:13 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/29/2025
7:01 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
3:41 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form DEFA14A
04/25/2025
1:57 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SCHEDULE 13G
04/16/2025
3:35 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:29 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
6:04 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
6:50 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
6:04 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
6:06 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
5:59 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:28 AM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
01/27/2025
6:04 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:25 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SCHEDULE 13D/A
01/15/2025
3:08 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
11:15 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/13/2025
11:15 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/13/2025
3:09 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:04 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2025
11:15 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/09/2025
11:15 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/09/2025
11:15 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
01/10/2025
5:00 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form POS AM
01/10/2025
5:01 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form POS AM
01/08/2025
3:33 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 424B7
01/08/2025
3:38 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 424B7
01/08/2025
3:30 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 424B3
01/07/2025
7:04 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Davis Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:04 PM
Brunn Carsten (Reporting)
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:05 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:05 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:05 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:05 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:21 PM
Brunn Carsten (Reporting)
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:14 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play (Ad)

While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it could transform warfare, robotics, and the global economy. But you don’t need to buy Tesla or wait for xAI to IPO to benefit. One overlooked public company is supplying the critical tech behind Musk’s AI push — and it trades for a fraction of Nvidia’s price. Hedge funds are already loading up, but most investors haven’t noticed yet.tc pixel

See the full details on this “backdoor” Musk bet here
12/30/2024
3:11 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
English Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
7:22 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SCHEDULE 13D/A
12/23/2024
4:20 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:16 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
12/11/2024
3:28 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:21 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
3:36 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
5:03 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
5:50 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:51 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Singer Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:52 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:45 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
8:44 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SC 13D/A
11/18/2024
6:28 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Miljkovic Milos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
6:32 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kurtoglu Metin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
6:35 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
6:23 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Jewell Christopher M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:24 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
4:07 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kurtoglu Metin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:31 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/07/2024
6:06 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:19 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
3:53 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Kalayoglu Murat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:30 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
Kalayoglu Murat (Filed by)
Form SC 13D/A
10/15/2024
3:43 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
Hoge Elizabeth (Reporting)
Seven One Eight Three Four Irrevocable Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
5:08 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SC 13D/A
10/04/2024
4:58 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
11:15 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form EFFECT
10/01/2024
3:36 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 424B7
09/27/2024
3:13 PM
Cartesian Therapeutics, Inc. (Issuer)
Cartesian Therapeutics (Issuer)
SPRINGER TIMOTHY A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:20 PM
Cartesian Therapeutics, Inc. (Subject)
Cartesian Therapeutics (Subject)
SPRINGER TIMOTHY A (Filed by)
Form SC 13D/A
09/26/2024
6:02 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
6:03 AM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:17 PM
Cartesian Therapeutics, Inc. (Filer)
Cartesian Therapeutics (Filer)
Form S-1/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RNAC) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners